Literature DB >> 18336589

Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease.

K Nara1, M S Kurokawa, S Chiba, H Yoshikawa, S Tsukikawa, T Matsuda, N Suzuki.   

Abstract

The involvement of excessive T helper 1 (Th1) cell functions in the pathogenesis of Behçet's disease (BD) has been reported. We therefore studied Toll-like receptor (TLR)-expressing cells, which play important roles in innate immunity in patients with BD. Peripheral blood mononuclear cells (PBMC) of BD and healthy controls, and tissue specimens of intestinal BD and Crohn's disease (CD) were analysed for messenger RNA (mRNA) and protein expressions by reverse transcription-polymerase chain reaction and immunostaining respectively. PBMC of BD expressed TLR-2 and TLR-4 mRNA almost comparable with healthy controls. Intestinal lesions of BD expressed TLR-2 and TLR-4 mRNA consistently. In contrast, TLR-4 mRNA was expressed preferentially and TLR-2 mRNA was expressed less frequently in CD lesions. In intestinal samples of BD, TLR-2 and TLR-4 mRNA were detected in ileocaecal ulcer lesions, but not in unaffected sites of the same sample, indicating the association of the TLR expression with the disease manifestation of intestinal BD. TLR-2-expressing cells which were simultaneously cluster of distribution (CD)68-positive produced interleukin (IL)-12 in the lesions, indicating the participation of TLR-2-expressing cells in the Th1 skewed responses in vivo. As a possible ligand of TLR-2, in BD self-heat shock protein 60 was expressed in peripheral blood lymphocytes and intestinal tissues. Collectively, TLR-2-expressing cells as well as TLR-4-expressing cells accumulated in the intestinal lesions of BD. IL-12 produced by TLR-2-expressing cells may contribute to the induction of Th1-dominant immune responses in intestinal BD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336589      PMCID: PMC2384098          DOI: 10.1111/j.1365-2249.2008.03626.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Immunopathogenesis of Behçet's disease.

Authors:  T Lehner
Journal:  Ann Med Interne (Paris)       Date:  1999-10

3.  Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet's disease.

Authors:  M Naganuma; Y Iwao; N Inoue; T Hisamatsu; H Imaeda; H Ishii; T Kanai; M Watanabe; T Hibi
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

4.  The extra domain A of fibronectin activates Toll-like receptor 4.

Authors:  Y Okamura; M Watari; E S Jerud; D W Young; S T Ishizaka; J Rose; J C Chow; J F Strauss
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

5.  Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells.

Authors:  R M Vabulas; P Ahmad-Nejad; C da Costa; T Miethke; C J Kirschning; H Häcker; H Wagner
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

6.  Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.

Authors:  R I Tapping; S Akashi; K Miyake; P J Godowski; P S Tobias
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

7.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

8.  Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation.

Authors:  M Hausmann; S Kiessling; S Mestermann; G Webb; T Spöttl; T Andus; J Schölmerich; H Herfarth; K Ray; W Falk; G Rogler
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

9.  Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

Authors:  Christian Termeer; Frauke Benedix; Jonathon Sleeman; Christina Fieber; Ursula Voith; Thomas Ahrens; Kensuke Miyake; Marina Freudenberg; Christopher Galanos; Jan Christoph Simon
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.

Authors:  C J Kirschning; H Wesche; T Merrill Ayres; M Rothe
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  19 in total

1.  Hsp60 and Hsp10 increase in colon mucosa of Crohn’s disease and ulcerative colitis.

Authors:  Vito Rodolico; Giovanni Tomasello; Monica Zerilli; Anna Martorana; Alessandro Pitruzzella; Antonella Marino Gammazza; Sabrina David; Giovanni Zummo; Provvidenza Damiani; Salvatore Accomando; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Cell Stress Chaperones       Date:  2010-11       Impact factor: 3.667

Review 2.  Behçet's disease-like syndrome secondary to microbial infection: a case report and review of the literature.

Authors:  Lingshu Zhang; Yuan Xu; Yun Peng; Bing Yan; Yi Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Structure-activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides.

Authors:  Wenyan Wu; Rongti Li; Subbalakshmi S Malladi; Hemamali J Warshakoon; Matthew R Kimbrell; Michael W Amolins; Rehman Ukani; Apurba Datta; Sunil A David
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

Review 4.  Behcet's Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management.

Authors:  Anthony Nguyen; Shubhra Upadhyay; Muhammad Ali Javaid; Abdul Moiz Qureshi; Shahan Haseeb; Nismat Javed; Christopher Cormier; Asif Farooq; Abu Baker Sheikh
Journal:  Inflamm Intest Dis       Date:  2021-11-04

5.  Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet's disease.

Authors:  Wenjie Zheng; Xiaoman Wang; Jinjing Liu; Xin Yu; Lu Li; Heping Wang; Jijun Yu; Xiaoya Pei; Chaoran Li; Zhimian Wang; Menghao Zhang; Xiaofeng Zeng; Fengchun Zhang; Chenfei Wang; Hua Chen; Hou-Zao Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-21       Impact factor: 12.779

6.  Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.

Authors:  Fabricio Souza Neves; Solange Carrasco; Cláudia Goldenstein-Schainberg; Célio Roberto Gonçalves; Suzana Beatriz Veríssimo de Mello
Journal:  Clin Rheumatol       Date:  2009-08-25       Impact factor: 2.980

7.  Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.

Authors:  Fatmazohra Djaballah-Ider; Zineb Djeraba; Mourad Chemli; Nadjiba Dammene-Debbihe; Doulkifly Lounis; Houda Belguendouz; Yanis Medour; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-29       Impact factor: 4.473

8.  Analysis of Th Cell-related Cytokine Production in Behçet Disease Patients with Uveitis Before and After Infliximab Treatment.

Authors:  Masaru Takeuchi; Yoko Karasawa; Kohzou Harimoto; Atsushi Tanaka; Masaki Shibata; Tomohito Sato; Rachel R Caspi; Masataka Ito
Journal:  Ocul Immunol Inflamm       Date:  2016-04-12       Impact factor: 3.070

9.  NOD2 is highly expressed in Behçet disease with pulmonary manifestations.

Authors:  Kamel Hamzaoui; Hanadi Abid; Anissa Berraies; Jamel Ammar; Agnès Hamzaoui
Journal:  J Inflamm (Lond)       Date:  2012-02-13       Impact factor: 4.981

10.  Aberrant Activation of Heat Shock Protein 60/65 Reactive T Cells in Patients with Behcet's Disease.

Authors:  Jun Shimizu; Tomoko Izumi; Noboru Suzuki
Journal:  Autoimmune Dis       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.